Alexandria Real Estate Equities (NYSE:ARE) Posts Quarterly Earnings Results, Misses Expectations By $3.71 EPS

Alexandria Real Estate Equities (NYSE:ARE – Get Free Report) released its quarterly earnings results on Monday. The real estate investment trust reported ($3.74) EPS for the quarter, missing analysts’ consensus estimates of ($0.03) by ($3.71), FiscalAI reports. The business had revenue of $671.18 million for the quarter, compared to analysts’ expectations of $646.26 million. The firm’s quarterly revenue was down 10.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.22 EPS.

Alexandria Real Estate Equities Trading Down 1.3%

ARE opened at $40.31 on Wednesday. The company’s 50-day moving average price is $48.68 and its two-hundred day moving average price is $49.90. Alexandria Real Estate Equities has a twelve month low of $39.41 and a twelve month high of $63.60.

Alexandria Real Estate Equities Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, October 15th. Stockholders of record on Wednesday, September 30th were issued a $0.72 dividend. The ex-dividend date of this dividend was Wednesday, September 30th. This represents a $2.88 annualized dividend and a dividend yield of 7.1%.

More Alexandria Real Estate Equities News

Here are the key news stories impacting Alexandria Real Estate Equities this week:

  • Positive Sentiment: Third-quarter adjusted FFO of $1.54 per share and revenue of $671.2 million exceeded consensus estimates of $1.52 and $646.3 million, respectively. Strong leasing activity and improved sales helped support the operating results. Alexandria Q3 FFO and Revenues Surpass Estimates
  • Positive Sentiment: Alexandria reaffirmed its 2026 adjusted FFO outlook at a midpoint of $6.40 per share and outlined a year-end net leverage target of 5.6x to 6.2x, offering some reassurance about capital management. Alexandria Leverage Goal and FFO Outlook
  • Positive Sentiment: KKR agreed to invest $475 million in Alexandria’s Campus Point life-sciences campus, providing external capital and validating the value of a major asset during a difficult funding environment. KKR Invests in Campus Point
  • Neutral Sentiment: Alexandria is advancing plans to redevelop the Tanforan mall site in San Bruno, potentially creating long-term development value, although the project will require capital and face execution risks. San Bruno Mall Redevelopment
  • Negative Sentiment: ARE reported a third-quarter net loss of $3.74 per share, versus a $2.22 profit a year earlier. Revenue declined 10.7% year over year, while property impairments weighed heavily on reported earnings. Alexandria Third-Quarter Results
  • Negative Sentiment: BNP Paribas Exane cut its price target from $40 to $37 and assigned an “underperform” rating. Cantor Fitzgerald also reduced its target from $52 to $42 and moved to “neutral,” reinforcing concerns about occupancy, rental rates and the life-sciences real estate downturn. BNP Paribas Exane Analyst Action
  • Negative Sentiment: The sale of a nearly completed Fenway lab tower and stakes in major campuses highlights Alexandria’s efforts to raise capital, but also underscores weak Boston laboratory demand and elevated vacancy, reported at 28.9%. Fenway Lab Tower Sale

Insider Transactions at Alexandria Real Estate Equities

In other Alexandria Real Estate Equities news, EVP Kristina Fukuzaki-Carlson sold 16,810 shares of the stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $50.51, for a total value of $849,073.10. Following the sale, the executive vice president directly owned 39,152 shares in the company, valued at $1,977,567.52. This represents a 30.04% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Chairman Joel S. Marcus bought 5,000 shares of the stock in a transaction that occurred on Friday, September 11th. The stock was bought at an average cost of $49.68 per share, for a total transaction of $248,400.00. Following the completion of the purchase, the chairman directly owned 597,724 shares of the company’s stock, valued at $29,694,928.32. This represents a 0.84% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 1.35% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. JPMorgan Chase & Co. lowered Alexandria Real Estate Equities from a “neutral” rating to an “underweight” rating and set a $56.00 price target on the stock. in a research note on Thursday, September 24th. Citigroup raised their target price on shares of Alexandria Real Estate Equities from $42.00 to $50.00 and gave the stock a “neutral” rating in a report on Monday, August 10th. Wall Street Zen downgraded shares of Alexandria Real Estate Equities from a “hold” rating to a “sell” rating in a research note on Saturday, August 8th. Weiss Ratings reiterated a “sell (d)” rating on shares of Alexandria Real Estate Equities in a research note on Thursday, October 15th. Finally, Evercore reiterated an “outperform” rating and issued a $59.00 target price on shares of Alexandria Real Estate Equities in a research note on Monday, September 21st. Two equities research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and four have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Reduce” and an average price target of $49.93.

Check Out Our Latest Stock Analysis on Alexandria Real Estate Equities

About Alexandria Real Estate Equities

(Get Free Report)

Alexandria Real Estate Equities, Inc (NYSE:ARE) is a real estate investment trust that owns, operates and develops collaborative life science, agtech and advanced technology campuses. Its properties are designed for companies, research institutions and government agencies engaged in biotechnology, pharmaceuticals, medical devices, agriculture technology and related fields.

The company provides laboratory, office and research space, along with supporting amenities and infrastructure intended to foster collaboration among its tenants.

Read More

Earnings History for Alexandria Real Estate Equities (NYSE:ARE)

Receive News & Ratings for Alexandria Real Estate Equities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alexandria Real Estate Equities and related companies with MarketBeat.com's FREE daily email newsletter.